Form C Mileberry Inc
- Wall Street mints big gains to end strong week
- JP Morgan's Kolanovic Predicts No Recession and Next Week's Rebalancing Could Drive Stocks Up 7%
- U.S. Supreme Court overturns Roe v. Wade, ends constitutional right to abortion
- FedEx (FDX) Gains on Solid FY23 Outlook, Analysts Mostly Bulled Up Into Next Week's Investors Day
- Get Ready for a 10% Rally in S&P 500
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
C 0001929449 XXXXXXXX LIVE false false true Mileberry Inc Corporation DE 01-04-2022 548 Market Street San Francisco CA 94104 mileberry.com Y Mileberry I, a series of Wefunder SPV, LLC Limited Liability Company DE 05-24-2022 4104 24TH ST PMB 8113 San Francisco CA 94114 https://wefunder.com/ Mileberry I EB, a series of Wefunder SPV, LLC Limited Liability Company DE 05-24-2022 4104 24TH ST PMB 8113 San Francisco CA 94114 https://wefunder.com/ Wefunder Portal LLC 0001670254 007-00033 283503 7.5% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering. No Other Simple Agreement for Future Equity (SAFE) 50000 1.00000 Pro-rated portion of the total principal value of $50,000; interests will be sold in increments of $1; each investment is convertible to one share of stock as described under Item 13. 50000.00 Y Other As determined by the issuer 1070000.00 04-30-2023 15 647100.00 0.00 500100.00 0.00 0.00 0.00 0.00 0.00 500000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -90000.00 0.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY B5 GU PR VI 1V Mileberry Inc Roman Novozhenov CEO Andreas Wuzke Chief Business Development Officer 05-18-2022 Roman Novozhenov CEO 05-18-2022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™
- Non-work related loss of life
- MoveRich (MVRC) Is Now Available for Trading on LBank Exchange
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!